BNT162a1 SARS-CoV-2 Vaccine

Ask the supplier | View on supplier's website

BNT162a1 is one of four advanced mRNA-based vaccines being developed through \"Project Lightspeed,\" a joint program between Pfizer and BioNTech. BNT162a1 is a uridine mRNA (uRNA) vaccine formulated in lipid nanoparticles for delivery via intramuscular injection.BNT162a1 is undergoing evaluation in clinical trials in both the USA (NCT04368728) and Germany (NCT04380701).

Supplier	Creative Biomart
Product #	THP-0325
Pricing	1 vial : USD $2998

Feedback